TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Operating margin 2023–2025
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) operating margin by fiscal year — reported operating income divided by reported revenue.
-959.1%FY2025 · since FY2023: -1523.9% → -959.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -959.1% | +395.2 pp |
| FY2024 | -1354.3% | +169.7 pp |
| FY2023 | -1523.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TNXP financial trends
TNXP RevenueTNXP Net incomeTNXP Net marginTNXP Gross profitTNXP Gross marginTNXP Operating incomeTNXP Operating cash flowTNXP Free cash flowTNXP Capital expendituresTNXP Return on equityTNXP Stock buybacksTNXP Dividends paidTNXP Total assetsTNXP Total liabilitiesTNXP Shareholders’ equityTNXP overview →